Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Non-cash Items (2016 - 2025)

Syndax Pharmaceuticals (SNDX) has disclosed Non-cash Items for 11 consecutive years, with $56.9 million as the latest value for Q4 2025.

  • For Q4 2025, Non-cash Items rose 483.63% year-over-year to $56.9 million; the TTM value through Dec 2025 reached $56.9 million, up 483.63%, while the annual FY2025 figure was $56.9 million, 755.01% up from the prior year.
  • Non-cash Items hit $56.9 million in Q4 2025 for Syndax Pharmaceuticals, up from $9.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $88.0 million in Q4 2022 and bottomed at $83000.0 in Q1 2022.
  • Average Non-cash Items over 5 years is $39.7 million, with a median of $43.4 million recorded in 2021.
  • Year-over-year, Non-cash Items plummeted 99.74% in 2022 and then soared 93634.94% in 2023.
  • Syndax Pharmaceuticals' Non-cash Items stood at $68.6 million in 2021, then increased by 28.29% to $88.0 million in 2022, then tumbled by 37.41% to $55.1 million in 2023, then tumbled by 82.31% to $9.7 million in 2024, then surged by 483.63% to $56.9 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $56.9 million, $9.7 million, and $55.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.